Literature DB >> 1711864

Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors.

M Arendrup1, J E Hansen, H Clausen, C Nielsen, L R Mathiesen, J O Nielsen.   

Abstract

Three virus isolates HTLV-IIIB/lyA, HTLV-IIIB/lyB and HTLV-IIIB/lyO, obtained by passaging and propagating the HTLV-IIIB/H9 isolate in three separate cultures of mixed peripheral blood mononuclear cells (PBMC) from donors of blood type A, B or O, respectively, were tested for susceptibility for virus neutralization by the monoclonal antibody (MAb) AH16 directed against the blood group A epitope. MAb AH16 was previously shown to inhibit cell-free virus infection using HTLV-IIIB propagated in H9 cells. AH16 showed a concentration-dependent inhibition of the HTLV-IIIB/lyA isolate but did not inhibit the HTLV-IIIB/lyB or the HTLV-IIIB/lyO isolate. Specificity of the MAb-mediated inhibition was shown using A-antigen (tetrasaccharide). Thus, HIV infection of PBMC from donors with blood type A appears to induce expression of host-cell-encoded carbohydrate blood group A epitope on HIV which can be a target for MAb-mediated virus neutralization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711864     DOI: 10.1097/00002030-199104000-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  17 in total

1.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

2.  Modulation of gene expression in CD4+ T lymphocytes following in vitro HIV infection: a comparison between human and chimpanzee.

Authors:  Pol-André Apoil; Arnaud Gleizes; Bénédicte Puissant-Lubrano; Lionel Forestier; Raymond Julien; Peter Winterton; Christophe Pasquier; Jacques Izopet; Antoine Blancher
Journal:  Virusdisease       Date:  2015-06-06

Review 3.  Peptide mimotopes of carbohydrate antigens.

Authors:  T Kieber-Emmons
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.

Authors:  J E Hansen; C Nielsen; M Arendrup; S Olofsson; L Mathiesen; J O Nielsen; H Clausen
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 5.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

6.  Efficacy of HIV-specific and 'antibody-independent' mechanisms for complement activation by HIV-infected cells.

Authors:  M N Saarloos; T F Lint; G T Spear
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

7.  Evolution of the human ABO polymorphism by two complementary selective pressures.

Authors:  Robert M Seymour; Martin J Allan; Andrew Pomiankowski; Kenth Gustafsson
Journal:  Proc Biol Sci       Date:  2004-05-22       Impact factor: 5.349

8.  Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya.

Authors:  Nadia Musimbi Chanzu; Walter Mwanda; Julius Oyugi; Omu Anzala
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 9.  The role of red blood cells in enhancing or preventing HIV infection and other diseases.

Authors:  Modisa S Motswaledi; Ishmael Kasvosve; Oluwafemi O Oguntibeju
Journal:  Biomed Res Int       Date:  2013-10-10       Impact factor: 3.411

10.  The Higher Frequency of Blood Group B in a Brazilian Population with HIV Infection.

Authors:  Tor Gunnar Hugo Onsten; Sidia Maria Callegari-Jacques; Luciano Zubaran Goldani
Journal:  Open AIDS J       Date:  2013-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.